Patient Guide: A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 9 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05364424
Status: ACTIVE_NOT_RECRUITING
Condition: Diffuse Large B-Cell Lymphoma (DLBCL)
Phase: PHASE1

Find a Study Location Near You

This study is available at 9 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Orange, California
  • Pembroke Pines, Florida
  • Chicago, Illinois
  • • And 6 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily